Fidelity Investments’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
Other funds holding LSTA
SFCM
Fidelity Investments's LSTA Position: Q3 2026 in Review
Fidelity Investments opened a new position in Lisata Therapeutics (LSTA) in Q3 2026: 8 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #5706 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in LSTA as recently as Q2 2023.
Fidelity Investments first reported a position in LSTA in Q1 2020 and has held it in 6 quarters since. The position peaked at $1K in Q1 2020. 39 funds tracked by Wall St. Rank hold LSTA as of Q3 2026.
- Fidelity Investments held 8 shares of Lisata Therapeutics worth $12 as of Q3 2026.
- Lisata Therapeutics was a new Fidelity Investments position in Q3 2026.
- Lisata Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5706 holding.
- Fidelity Investments first reported a position in Lisata Therapeutics in Q1 2020 and has held it in 6 quarters since.
- Fidelity Investments's Lisata Therapeutics position peaked at $1K in Q1 2020.
- 39 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.